CNBC’s Brandon Gomez reports on the Trump administration’s move to reclassify cannabis as a Schedule III drug. The change doesn’t legalize the drug at the federal level but it could significantly expand scientific research in the drug’s medical uses.
What The Trump Administration’s Move To Reclassify Marijuana Means For Investors
